Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma

BACKGROUND: Sorafenib was the first Food and Drug Administration approved anti-angiogenic therapy for renal cell carcinoma (RCC). Currently, there are no validated predictive biomarkers for sorafenib. Our purpose was to determine if sorafenib target expression is predictive of sorafenib sensitivity....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Aziz, Saadia A, Sznol, Joshua A, Albiges, Laurence, Zito, Christopher, Jilaveanu, Lucia B, Camp, Robert L, Escudier, Bernard, Kluger, Harriet M
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2014
Fag:
Primary Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3896780/
https://ncbi.nlm.nih.gov/pubmed/24423208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2867-14-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker